Tenascin-C, a prognostic determinant of esophageal Squamous cell carcinoma

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Yang, Zhao Ting ^a   Yeo, So Young ^b,c   Yin, Yong Xue ^a   Lin, Zhen Hua ^a   Lee, Hak Min ^b,c   Xuan, Yan Hua ^a   Cui, Yan ^a   Kim, Seok Hyung ^b,c  

^a YANBIAN UNIVERSITY   (China)

^b Sungkyunkwan University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST ACTIVATION PROTEIN; FIBROBLAST STIMULATING PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA; PLATELET DERIVED GROWTH FACTOR BETA; SMOOTH MUSCLE ACTIN; TENASCIN; TUMOR MARKER; UNCLASSIFIED DRUG;

AGE; AGED; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR CELL CULTURE; TUMOR CELL LINE;

AGED; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TENASCIN; TUMOR CELLS, CULTURED;

EID: 84953791947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145807     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, and Forman D. Global cancer statistics. J CA Cancer Clin 2011; 61(2):69-90.
2. Ghert MA, Qi WN, Erickson HP, Block JA, Scully SP. Tenascin-C splice variant adhesive/anti-Adhesive effects on chondrosarcoma cell attachment to fibronectin. J Cell Struct Funct 2001; 26(3):179-187.
3. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. J Cancer Lett 2006; 244 (2):143-163.
4. Brellier F, Chiquet-Ehrismann R. How do tenascins influence the birth and life of a malignant cell. J Cell Mol Med 2012; 16(1):32-40. doi: 10.1111/j.1582-4934.2011.01360.x
5. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 2003; 200(4):488-499.
6. Ha SY, Yeo SY, Xuan YH, Kim SH. The prognostic significance of cancer-Associated fibroblasts in esophageal squamous cell carcinoma. PLoS One 2014; 9(6):1-9.
7. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001; 23: 291-299.
8. van Diest P J, van Dam P, Henzen-Logmans S C, Berns E, van der Burg M E, Green J, et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. J Clin Pathol 1997 Oct; 50(10): 801-804.
9. Wu Shang-Gin, Chang Yih-Leong, Lin Jou-Wei, Wu Chen-Tu, Chen Hsuan-Yu, Tsai Meng-Feng, et al. Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction. PLos One 2011; 6(8):23303-11.
10. Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples. PLoS One 2014; 9(5):96801-12.
11. Hindermann W1, Berndt A, Borsi L, Luo X, Hyckel P, Katenkamp D, et al. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol 1999 Dec; 189(4):475-80.
12. Tsunoda T1, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, et al. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 2003 Jun; 162(6):1857-67.
13. Nong Y, Wu D, Lin Y, Zhang Y, Bai L, Tang H. Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells. J Am Cancer Res 2015; 5(2):782-791.
14. Parekh K, Ramachandran S, Cooper J, Bigner D, Patterson A, Mohanakumar T. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes. J Lung Cancer 2005; 47(1):17-29.
15. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 2011; 17(7):867-874. doi: 10.1038/nm.2379
16. Tastekin D, Tas F, Karabulut S, Duranyildiz D, Serilmez M, Guveli M, et al. Clinical significance of serum tenascin-C levels in breast cancer. J Tumour Biol 2014; 35(7):6619-6625.
17. Gebb SA, Jones PL. Hypoxia and lung branching morphogenesis. Adv Exp Med Biol 2003; 543:117-125.
18. Anderberg C, Li H, Fredriksson L, Andrae J, Betsholtz C, Li X, et al. Paracrine signaling by plateletderived growth factor-CC promotes tumor growth by recruitment of cancer-Associated fibroblasts. Cancer Res 2009; 69:369-378. doi: 10.1158/0008-5472.CAN-08-2724
19. Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumormicroenvironment. J Cancer Biol Ther 2006; 5: 1640-1646.
20. Paulsson J, Sjoblom T, Micke P, Ponten F, Landberg G, Heldin CH, et al. Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am Pathol 2009; 175:334-341.
21. Ueno H, Shinto E, Shimazaki H, Kajiwara Y, Sueyama T, Yamamoto J, et al. Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis. Ann Surg Oncol 2015; 22(5):1504-1512. doi: 10.1245/s10434-014-4149-9